Detection of alpha-1 antitrypsin deficiency: the past, present and future

BACKGROUND: Most patients with alpha-1 antitrypsin deficiency remain undiagnosed and therefore do not benefit from current therapies or become eligible for research studies of new treatments under development. Improving the detection rate for AATD is therefore a high priority for the Alpha-1 Foundat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Orphanet J Rare Dis
Main Authors: Brantly, Mark, Campos, Michael, Davis, Angela M., D’Armiento, Jeanine, Goodman, Kenneth, Hanna, Kathi, O’Day, Miriam, Queenan, John, Sandhaus, Robert, Stoller, James, Strange, Charlie, Teckman, Jeffrey, Wanner, Adam
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7168939/
https://ncbi.nlm.nih.gov/pubmed/32306990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01352-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares